Letter to the Editor: Revisit the Combination Validation Test of Tsong et al. for Thorough QT/QTc Clinical Trials

被引:1
|
作者
Sun, Guowen [1 ]
Quan, Hui [1 ]
机构
[1] Sanofi Aventis, Biostat & Programming, Bridgewater, NJ 08807 USA
关键词
D O I
10.1080/10543400903254790
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:683 / 687
页数:5
相关论文
共 50 条
  • [1] Response to Letter to the Editor: Validation Testing in Thorough QT/QTc Clinical Trials by Yi Tsong et al.
    Tsong, Yi
    Zhong, Jinglin
    Chen, Wen Jen
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (03) : 688 - 688
  • [2] Validation testing in thorough QT/QTc clinical trials
    Tsong, Yi
    Zhong, Jinglin
    Chen, Wen Jen
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2008, 18 (03) : 529 - 541
  • [3] Letter to the Editor: Statistical Issues of QT Prolongation Assessment Based on Linear Concentration Modeling by Yi Tsong et al.
    Wang, Yaning
    Garnett, Christine
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (03) : 689 - 692
  • [4] Response to Letter to the Editor: Statistical Issues of QT Prolongation Assessment Based on Linear Concentration Modeling by Yi Tsong et al.
    Tsong, Yi
    Shen, Meiyu
    Zhong, Jinglin
    Zhang, Joanne
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (03) : 693 - 697
  • [5] Multiple Comparisons of Repeatedly Measured Response: Issues of Validation Testing in Thorough QT/QTc Clinical Trials
    Tsong, Yi
    Yan, Lihan K.
    Zhong, Jinglin
    Nie, Lei
    Zhang, Joanne
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (03) : 654 - 664
  • [6] Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects, Dixon et al. 2008; request for publication of PR interval data
    Rudd, G. David
    Sake, John-Kenneth
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (06) : 963 - 963
  • [7] Choosing Appropriate Estimands in Clinical Trials (Leuchs et al): Letter to the Editor
    Garrett, Andrew
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (04) : 601 - 601
  • [8] Choosing Appropriate Estimands in Clinical Trials (Leuchs et al): Letter to the Editor
    Andrew Garrett
    [J]. Therapeutic Innovation & Regulatory Science, 2015, 49 : 601 - 601
  • [9] Response to letter to editor: ‘Comment on Arch et al., Trials. 2016;17:517’
    B. N. Arch
    J. Blair
    A. McKay
    J. W. Gregory
    P. Newland
    C. Gamble
    [J]. Trials, 18
  • [10] Response to letter to editor: 'Comment on Arch et al., Trials. 2016;17:517'
    Arch, B. N.
    Blair, J.
    Mckay, A.
    Gregory, J. W.
    Newland, P.
    Gamble, C.
    [J]. TRIALS, 2017, 18